The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase III, open-label, randomized comparison of AS1413 (amonafide L-malate) plus cytarabine with daunorubicin plus cytarabine in secondary acute myeloid leukemia (ACCEDE).
R. M. Stone
Consultant or Advisory Role - Antisoma
Research Funding - Antisoma
S. L. Allen
Consultant or Advisory Role - Antisoma
Research Funding - Antisoma
A. Pigneux
No relevant relationships to disclose
R. K. Stuart
Consultant or Advisory Role - Antisoma; Boehringer Ingelheim; Sunesis Pharmaceuticals
Research Funding - Antisoma; Boehringer Ingelheim; Novartis; Seattle Genetics; Sunesis Pharmaceuticals
Expert Testimony - Sunesis Pharmaceuticals
M. Wetzler
No relevant relationships to disclose
D. Rizzieri
Research Funding - Antisoma
H. P. Erba
Research Funding - Antisoma
L. E. Damon
No relevant relationships to disclose
J. H. Jang
No relevant relationships to disclose
M. S. Tallman
No relevant relationships to disclose
K. Warzocha
No relevant relationships to disclose
T. Masszi
Research Funding - Antisoma
M. A. Sekeres
No relevant relationships to disclose
E. Miklos
No relevant relationships to disclose
H. Horst
No relevant relationships to disclose
D. L. D. Selleslag
Research Funding - Antisoma
S. R. Solomon
No relevant relationships to disclose
P. Venugopal
Research Funding - Antisoma
A. S. Lundberg
Consultant or Advisory Role - Antisoma
Stock Ownership - Antisoma
B. L. Powell
Consultant or Advisory Role - Antisoma
Research Funding - Antisoma